ReconDose
DashboardCalculatorScheduleDose LogFood
All peptides

BPC-157

Recovery / injury

This information is for research and educational purposes only. It is not medical advice. Always consult a qualified professional and follow applicable regulations.

Typical vial

5 mg

Common dose

0.25 mg

Frequency

7×/week

Half-life

Calculate BPC-157 reconstitution

Open the free calculator pre-filled with BPC-157 values — no account needed.

Open BPC-157 calculator

Dosing & Protocol Overview

Typical vial size5 mg
Common dose per injection0.25 mg
Frequency7× per week (daily)
Cycle patternCyclic — 42 days on, 28 days off (~4 cycles/year)
CategoryRecovery / injury

Research Notes

Research protocols vary; some are administered near the area of interest.

How Reconstitution Works

Reconstitution is the process of mixing a lyophilized (freeze-dried) peptide powder with bacteriostatic water to create an injectable solution. The concentration depends on how much BAC water you add to the vial.

For a 5 mg vial of BPC-157, the calculator works out the mg/ml concentration based on your BAC water volume, then converts your target dose (0.25 mg) into the exact number of units to draw on an insulin syringe.

Try it now — pre-filled for BPC-157

Track Your BPC-157 Protocol

Once you've calculated your reconstitution, ReconDose lets you log every injection, build a dosing schedule, track side effects, and record biomarkers — all in one place. Create a free account to get started.

Research & References

The following publicly available studies are provided for research and educational purposes only. They are not medical advice. Click through to read the original publications.

Sikiric P, et al. · Current Pharmaceutical Design · 2007

Comprehensive review of BPC-157's beneficial effects on gastrointestinal lesions, pancreas, liver, heart, and wound/fracture healing. Describes interactions with dopamine, NO, prostaglandin, and somatosensory neuronal systems. Proposes BPC-157 as a physiological defense system peptide.

Tasar MH, et al. · PubMed · 2025· CC-BY

Rat model (n=24) showing BPC-157 (20 µg/kg IP) reduced oxidative stress markers (MDA, TOS), restored antioxidants (SOD, TAS), downregulated pro-apoptotic genes (p53, Bax, Casp3), and reduced inflammation. Histological analysis confirmed improved muscle architecture.

Sikiric P, et al. · Pharmaceuticals (MDPI) · 2025· CC-BY

Review addressing BPC-157's pleiotropic healing effects, angiogenesis modulation, and NO-system regulation. Reports high safety profile (LD1 not achieved), anti-tumor potential in vivo and in vitro, and counteraction of neurodegenerative disease models. Discusses corneal healing without neovascularization.

Sikiric P, et al. · Journal of Physiology (Paris) · 1993

Original research demonstrating BPC-157's protective effects against restraint stress, cysteamine, and ethanol-induced ulcers in rats. Showed strong endothelial protection via Monastral blue studies. The foundational study establishing BPC-157 as a cytoprotective agent.

Sikiric P, et al. · Journal of Physiology and Pharmacology (PMC) · 2019· CC-BY-NC

Open-access review of BPC-157 as a mediator of Robert's cytoprotection/organoprotection and Selye's stress coping response. Covers protection against alcohol, NSAIDs, and wound healing. Discusses endothelial protection, NO-system modulation, and dopamine/serotonin interactions.

Have a study we should add? Let us know. See our research hub for more studies and the Khavinson peptide bioregulator collection.

Related peptides